Board- Lisa Biegel
Sector: Contract Research Organization
Location: Madison, Wisconsin
About Covance Labs: As the drug development business of Laboratory Corporation of America Holdings (LabCorp) and the world’s most comprehensive drug development service company, Covance has helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today. Because of their broad experience and specialized expertise, they’re in a unique position to supply insights that go above and beyond testing. Together with their clients, they create solutions that transform potential into reality.
Bio Highlights: Lisa Biegel received a doctoral degree in Toxicology from the Texas A&M University, under Dr. Stephen Safe's guidance. She is currently the Executive Director and Global Lead for Safety Assessment at Covance Laboratories in Madison, Wisconsin. She has been with Covance for 19 years, working first as a Study Director for all types of regulatory mammalian toxicology studies for 6 years before moving into a full-time management role. As a Study Director, she has conducted well over 200 studies on pharmaceuticals and agricultural products. In her current role, she has managerial responsibilities for ~180 toxicology staff members, including study directors (Ph.D./DVM/Sr. Scientists), as well as staff in report production, publishing, and data management functions for Safety Assessment at four Covance sites (Madison, WI, Greenfield IN, Harrogate UK, Muenster Germany). She is responsible for ensuring regulatory compliance of studies and staff; is involved in setting the strategic direction for Covance Early Development, establishing training programs, identifying process improvements and efficiencies, and assisting in developing new service offerings.